[1]
“HEPATOPROTECTIVE AGENTS: DEFINITIONS, MECHANISMS, CLINICAL USE, AND PRACTICAL MONITORING”, ibmscr, vol. 6, no. 2, pp. 108–112, Feb. 2026, doi: 10.37547/.